Qingxin Xia
North China Institute of Science and Technology(CN)Zhengzhou University(CN)Henan Cancer Hospital(CN)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Gastric Cancer Management and Outcomes, Cancer Immunotherapy and Biomarkers, Cancer, Lipids, and Metabolism, Esophageal Cancer Research and Treatment
Most-Cited Works
- → The Scavenger Receptor MARCO Expressed by Tumor-Associated Macrophages Are Highly Associated With Poor Pancreatic Cancer Prognosis(2021)75 cited
- → Intratumoral Microbiome of Human Primary Liver Cancer(2022)72 cited
- → Artificial Intelligence-Assisted Score Analysis for Predicting the Expression of the Immunotherapy Biomarker PD-L1 in Lung Cancer(2022)56 cited
- → Unsupervised Factory Activity Recognition with Wearable Sensors Using Process Instruction Information(2019)43 cited
- → Using CloudSim to Model and Simulate Cloud Computing Environment(2013)42 cited
- → Pathological response and predictive role of tumour-infiltrating lymphocytes in HER2-positive early breast cancer treated with neoadjuvant pyrotinib plus trastuzumab and chemotherapy (Panphila): a multicentre phase 2 trial(2022)41 cited